Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Regenerative MedicineISSN: 2325-9620
Ian McNiece Author
Subjects of specialization
Affiliation
Stem Cell Transplantation, Cellular Therapy, Physiology, Hematology, Stem Cell Biology
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Tx, USA
Biography
Dr. McNiece has served as BioCardia's Chief Scientific Officer since 2017. He has more than 30 years of experience in stem cell biology and clinical manufacturing for bone marrow transplantation and cellular therapy clinical applications. He received his Ph.D. in physiology in 1986 from the University of Melbourne. He moved to the US in the same year as a postdoctoral fellow at the University of Virginia, Charlottesville, Virginia. He was Laboratory Head in the Department of Developmental Hematology at Amgen Inc. where he was involved in product development of Filgrastim, Neulasta, Stemgen, and led development of cellular therapies.
Publications
Editorial Open Access
Stem Cells and Regenerative Medicine
Author(s): Ian McNiece
Stem Cells and Regenerative Medicine
Regenerative medicine has been proposed to provide in the near future cures for debilitating diseases such as diabetes, cardiovascular disease, and Alzheimer’s disease. In particular, the use of stem cells to repair damaged tissues has led to a number of clinical trials in a range of diseases. However, despite the enormous potential of stem cells for regenerative medicine, there are many hurdles to overcome to develop these therapies. Although we are able to isolate, culture expand and differentiate stem cells in vitro, the requirements for in vivo survival, proliferation and differentiation into functional t... view more»
Social Media
Google Scholars / Researchers Sites
